BJMO - volume 14, issue 4, june 2020
J. Blokken PhD, PharmD, Tom Feys MBA, MSc
On the 14th and 15th of February 2020, the Belgian Society of Medical Oncology (BSMO) organised the 22nd annual BSMO meeting in Ghent. At this meeting, medical oncologists, oncologists in training and other specialists involved in the management of cancer patients again had the opportunity to gather as a community, exchange ideas and engage in cooperation.
(BELG J MED ONCOL 2020;14(4):171–7)
Read moreBJMO - volume 14, issue 4, june 2020
J. Blokken PhD, PharmD, Tom Feys MBA, MSc, W. Lybaert MD
On January 30-31st, 2020 the Masterclass on neuroendocrine tumours (NETs) took place in Antwerp, Belgium. This meeting was organised by NETwerk Antwerpen-Waasland (ENETS Centre of Excellence) with support from IPSEN. A broad plethora of presentations on molecular aspects, lung NETs, digestive NETs and neuroendocrine carcinomas (NECs), immunotherapy, Merkel cell carcinoma and patient-centred care were presented. This report will highlight the key messages of the symposium.
(BELG J MED ONCOL 2020;14(4):165–70)
Read moreBJMO - volume 14, issue 4, june 2020
J. Blokken PhD, PharmD, Tom Feys MBA, MSc
In this section of the BJMO, we aim to provide a snapshot of pivotal studies published in recent issues of the most important international journals focusing on oncology. Importantly, the selection of the studies discussed here is the sole responsibility of the publisher and was not influenced by third parties. Do you miss an important study, or did you read a hidden jewel that deserves to be shared with your colleagues? Please, let us know (editor@bjmo.be) and we will make sure to include it in the journal scan section of the next BJMO issue.
(BELG J MED ONCOL 2020;14(4):159–64)
Read moreBJMO - volume 14, issue 3, may 2020
Tom Feys MBA, MSc
On the 20th of February, BMUC again organised the post ASCO GU regional tour. During this meeting, which was simultaneously hosted at three locations throughout the country (Sint-Martens-Latem, Nijvel and Veerle), the key studies presented at this year’s ASCO GU meeting were discussed. Of note, this report will be based on the meeting held in Sint-Martens-Latem.
(BELG J MED ONCOL 2020;14(3):126–33)
Read moreBJMO - volume 14, issue 3, may 2020
J. Blokken PhD, PharmD, Tom Feys MBA, MSc
In this section of the BJMO, we aim to provide a snapshot of pivotal studies published in recent issues of the most important international journals focusing on oncology. Importantly, the selection of the studies discussed here is the sole responsibility of the publisher and was not influenced by third parties. Do you miss an important study, or did you read a hidden jewel that deserves to be shared with your colleagues? Please, let us know (editor@bjmo.be) and we will make sure to include it in the journal scan section of the next BJMO issue.
(BELG J MED ONCOL 2020;14(3):109–13)
Read moreBJMO - 2020, issue Special, march 2020
Tom Feys MBA, MSc, J. Beekwilder PhD
Radiotherapy (RT) plays a key role in the management of lung cancer and it is used at least once in over half of patients in both the curative and palliative setting. In recent years, the role of RT in the management of thoracic tumours is rapidly evolving. In this article we provide a brief overview of important RT developments in the past year.
Read moreBJMO - 2020, issue Special, march 2020
Tom Feys MBA, MSc
Small-cell lung cancer (SCLC) has defied the scientific community for decades. Chemotherapy has been the mainstay treatment for patients with SCLC and, unlike its non-small-cell counterpart, no significant therapeutic breakthroughs have been made since the 1970s. Recently, new immunotherapeutic and targeted therapy options became available for these patients. In this article, the results obtained with these therapeutic strategies are briefly discussed.
Read moreTo provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.